本研究旨在定性评估其配偶接受雄激素剥夺疗法的女性的生活经验。研究采用了常见现象学设计的目的样本，共有15名女性。数据按照Colaizzi的现象学分析步骤进行评估。参与者的观点被归类为七个主题：失去和悲伤、身体困难、社会经济困难、心理困难、关系变化、优势和利益。研究发现，接受ADT治疗的丈夫的妻子们经历了悲伤反应和身体、社会经济及心理困难。心理困难包括照顾负担、医院压力、性生活和倦怠感。观察到患者及其配偶经历了一些积极和消极的关系变化。对健康服务的满意度和抗逆力是女性配偶适应治疗过程的促进因素。研究还确定，在适应疾病和治疗过程时，参与者有一些需求，如家庭支持、经济支持、减少媒体的负面表述、提高医疗专业人员的沟通技巧。此外，他们发现与创伤后成长有关的一些好处。泌尿肿瘤护士可以提供旨在改善接受ADT治疗的丈夫妻子的福祉的服务，并利用泌尿肿瘤护理的知识和经验造福患者和照护者。©2023年作者，授权给德国斯普林格自然出版集团旗下的斯普林格出版有限公司。

This study was conducted to qualitatively evaluate the life experiences of women whose spouses had been receiving androgen deprivation therapy.The purposive sample of the research, in which a descriptive phenomenological design was used, consisted of 15 women. The data were evaluated according to Colaizzi's phenomenological analysis steps.The views of the participants were classified into 7 themes: loss and grief, physical difficulties, socioeconomic difficulties, psychological difficulties, relational changes, strengths, and benefits.It was determined that women whose husbands had been receiving ADT experienced grief responses and physical, socioeconomic, and psychological difficulties. Psychological difficulties were found to include care burden, hospital stress, sexuality, and burnout. It was observed that the patients and their spouses experienced some positive and negative relational changes. Satisfaction with health services and resilience were facilitating factors for female spouses to adapt to the treatment process. It was determined that during the adaptation to the disease and treatment process, the participants had some needs such as family support, economic support, reduction of negative representations in the media, and enhancement of communication skills of health professionals. Moreover, they were found to have some benefits related to post-traumatic growth. Uro-oncology nurses can develop services intended to improve the well-being of the wives of men receiving ADT and use the knowledge and experience of uro-oncology nursing for the benefit of both patients and caregivers.© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.